Molecular regulation of contractile smooth muscle cell phenotype: Implications for vascular tissue engineering

Tissue Engineering - Part B: Reviews

Volumn 16, Issue 5, 2010, Pages 467-491

  Beamish, Jeffrey A ^a   He, Ping ^a   Kottke Marchant, Kandice ^a,b   Marchant, Roger E ^a  

^a Case Western Reserve University   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATIONS; ENGINEERED TISSUES; EXTRACELLULAR MATRIX SYNTHESIS; MECHANICAL STIMULATION; MOLECULAR REGULATION; MOLECULAR UNDERSTANDING; NOVEL POLYMERS; PHENOTYPIC PLASTICITY; QUANTITATIVE ANALYSIS; SCAFFOLD SYSTEM; SIGNAL TRANSDUCTION PATHWAYS; SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; TISSUE-ENGINEERED SCAFFOLDS; VASCULAR TISSUE ENGINEERING;

CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION; HISTOLOGY; MUSCLE; SCAFFOLDS; SIGNAL TRANSDUCTION;

TISSUE ENGINEERING;

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADRENALIN; ALPHA ACTIN; ANGIOTENSIN II; BLOOD CLOTTING FACTOR 10A; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALDESMON; CALPONIN; CARBACHOL; ENDOTHELIN; ENDOTHELIN 1; HEPARIN; MYOSIN HEAVY CHAIN; POLYMER; PROTEIN; SEROTONIN; SMOOTHELIN A; SMOOTHELIN B; SOMATOMEDIN; THROMBIN; TISSUE SCAFFOLD; TRANSGELIN; UNCLASSIFIED DRUG;

CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTRACTION STRESS; EXTRACELLULAR MATRIX; GENE CONTROL; HUMAN; MECHANICAL STIMULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE;

ANIMALS; BLOOD VESSELS; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOTYPE; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 77957324486     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2009.0630     Document Type: Review

References (312)

1. Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T.B., Flegal, K., Ford, E., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M., Meigs, J., Mozaffarian, D., Nichol, G., ODonnell, C., Roger, V., Rosamond, W., Sacco, R., Sorlie, P., Stafford, R., Steinberger, J., Thom, T., Wasserthiel-Smoller, S., Wong, N., Wylie-Rosett, J., Hong, Y., and for the American Heart Association Statistics Committee and Stroke Statistics S. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, e21, 2009.
2. Laube, H.R., Duwe, J., Rutsch, W., and Konertz, W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg 120, 134, 2000.
3. Greenwald, S.E., and Berry, C.L. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol 190, 292, 2000.
4. Christen, T., Verin, V., Bochaton-Piallat, M., Popowski, Y., Ramaekers, F., Debruyne, P., Camenzind, E., van Eys, G., and Gabbiani, G. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 103, 882, 2001.
5. Sottiurai, V.S., Yao, J.S., Batson, R.C., Sue, S.L., Jones, R., and Nakamura, Y.A. Distal anastomotic intimal hyperplasia: histopathologic character and biogenesis. Ann Vasc Surg 3, 26, 1989.
6. Thyberg, J., Blomgren, K., Hedin, U., and Dryjski, M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res 281, 421, 1995.
7. Manderson, J.A., Mosse, P.R.L., Safstrom, J.A., Young, S.B., and Campbell, G.R. Balloon catheter injury to rabbit carotid-artery .1. Changes in smooth-muscle phenotype. Arteriosclerosis 9, 289, 1989.
8. Aikawa, M., Sakomura, Y., Ueda, M., Kimura, K., Manabe, I., Ishiwata, S., Komiyama, N., Yamaguchi, H., Yazaki, Y., and Nagai, R. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96, 82, 1997.
9. Kocher, O., Gabbiani, F., Gabbiani, G., Reidy, M.A., Cokay, M.S., Peters, H., and Huttner, I. Phenotypic features of smooth-muscle cells during the evolution of experimental carotid-artery intimal thickening-biochemical and morphological-studies. Lab Invest 65, 459, 1991.
10. Thyberg, J., Blomgren, K., Roy, J., Tran, P.K., and Hedin, U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem 45, 837, 1997.
11. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. Functional arteries grown in vitro. Science 284, 489, 1999.
12. Kawai-Kowase, K., and Owens, G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smoothmuscle cells.AmJ Physiol Cell Physiol 292, C59, 2007.
13. Owens, G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75, 487, 1995.
14. Stegemann, J.P., Hong, H., and Nerem, R.M. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol 98, 2321, 2005.
15. Campbell, J.H., and Campbell, G.R. Vascular Smooth Muscle in Culture. Boca Raton, FL: CRC Press, 1987.
16. Chamley-Campbell, J., Campbell, G.R., and Ross, R. The smooth muscle cell in culture. Physiol Rev 59, 1, 1979.
17. Hedin, U., and Thyberg, J. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 33, 239, 1987.
18. Rzucidlo, E.M., Martin, K.A., and Powell, R.J. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 45 Suppl A, A25, 2007.
19. Raines, E.W., Koyama, H., and Carragher, N.O. The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF. Ann N Y Acad Sci 902, 39; discussion 2, 2000.
20. Boerth, N.J., Dey, N.B., Cornwell, T.L., and Lincoln, T.M. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34, 245, 1997.
21. Chamley-Campbell, J.H., Campbell, G.R., and Ross, R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89, 379, 1981.
22. Kim, B.S., Nikolovski, J., Bonadio, J., Smiley, E., and Mooney, D.J. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res 251, 318, 1999.
23. Moussallem, M.D., Olenych, S.G., Scott, S.L., Keller, T.C., 3rd, and Schlenoff, J.B. Smooth muscle cell phenotype modulation and contraction on native and cross-linked polyelectrolyte multilayers. Biomacromolecules 10, 3062, 2009.
24. Hayashi, K., Saga, H., Chimori, Y., Kimura, K., Yamanaka, Y., and Sobue, K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulinlike growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273, 28860, 1998.
25. Potta, S.P., Liang, H., Pfannkuche, K., Winkler, J., Chen, S., Doss, M.X., Obernier, K., Kamisetti, N., Schulz, H., Hubner, N., Hescheler, J., and Sachinidis, A. Functional characterization and transcriptome analysis of embryonic stem cellderived contractile smooth muscle cells. Hypertension 53, 196, 2009.
26. Wang, Y., Zheng, X.R., Riddick, N., Bryden, M., Baur, W., Zhang, X., and Surks, H.K. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res 104, 531, 2009.
27. Rattan, S., Puri, R.N., and Fan, Y.P. Involvement of rho and rho-associated kinase in sphincteric smooth muscle contraction by angiotensin II. Exp Biol Med (Maywood) 228, 972, 2003.
28. Ledoux, J., Werner, M.E., Brayden, J.E., and Nelson, M.T. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 21, 69, 2006.
29. Teramoto, N. Physiological roles of ATP-sensitive K? channels in smooth muscle. J Physiol 572, 617, 2006.
30. Semenov, I., Wang, B., Herlihy, J.T., and Brenner, R. BK channel beta1-subunit regulation of calcium handling and constriction in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 291, L802, 2006.
31. Yunoki, T., Zhu, H.L., Iwasa, K., Tomoda, T., Aishima, M., Shibata, A., Naito, S., and Teramoto N. Comparative studies of ZD0947, a novel ATP-sensitive K(?) channel opener, on guinea pig detrusor and aortic smooth muscles. Naunyn Schmiedebergs Arch Pharmacol 376, 309, 2008.
32. L?Heureux, N., Stoclet, J.C., Auger, F.A., Lagaud, G.J., Germain, L., and Andriantsitohaina, R. A human tissueengineered vascular media: a newmodel for pharmacological studies of contractile responses. FASEB J 15, 515, 2001.
33. Hedin, U., Daum, G., and Clowes, A.W. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J Vasc Surg 27, 512, 1998.
34. Pukac, L., Huangpu, J., and Karnovsky, M.J. Plateletderived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res 242, 548, 1998.
35. Pukac, L.A., Carter, J.E., Ottlinger, M.E., and Karnovsky, M.J. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. J Cell Physiol 172, 69, 1997.
36. Daum, G., Hedin, U., Wang, Y., Wang, T., and Clowes, A.W. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ Res 81, 17, 1997.
37. Rauch, B.H., Millette, E., Kenagy, R.D., Daum, G., and Clowes, A.W. Thrombin-and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res 94, 340, 2004.
38. Hayashi, K., Shibata, K., Morita, T., Iwasaki, K., Watanabe, M., and Sobue, K. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 279, 40807, 2004.
39. Bingley, J.A., Hayward, I.P., Campbell, J.H., and Campbell, G.R. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo. J Vasc Surg 28, 308, 1998.
40. Lindner, V., Olson, N.E., Clowes, A.W., and Reidy, M.A. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J Clin Invest 90, 2044, 1992.
41. Millette, E., Rauch, B.H., Defawe, O., Kenagy, R.D., Daum, G., and Clowes, A.W. Platelet-derived growth factor-BBinduced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 96, 172, 2005.
42. Rauch, B.H., Millette, E., Kenagy, R.D., Daum, G., Fischer, J.W., and Clowes, A.W. Syndecan-4 is required for thrombininduced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 280, 17507, 2005.
43. Bono, F., Rigon, P., Lamarche, I., Savi, P., Salel, V., and Herbert, J.M. Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smoothmuscle cells. Biochem J 326 (Pt 3), 661, 1997.
44. Rapraeger, A.C., Krufka, A., and Olwin, B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705, 1991.
45. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841, 1991.
46. Kazi, M., Lundmark, K., Religa, P., Gouda, I., Larm, O., Ray, A., Swedenborg, J., and Hedin, U. Inhibition of rat smooth muscle cell adhesion and proliferation by nonanticoagulant heparins. J Cell Physiol 193, 365, 2002.
47. Kenagy, R.D., and Clowes, A.W. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors. Thromb Res 77, 55, 1995.
48. Savage, J.M., Gilotti, A.C., Granzow, C.A., Molina, F., and Lowe-Krentz, L.J. Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells. J Cell Physiol 187, 283, 2001.
49. Patel, R.C., Handy, I., and Patel, C.V. Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 22, 1439, 2002.
50. Zhao, Y., Xiao, W., and Templeton, D.M. Suppression of mitogen-activated protein kinase phosphatase-1 (MKP-1) by heparin in vascular smooth muscle cells. Biochem Pharmacol 66, 769, 2003.
51. Castellot, J.J., Wong, K., Herman, B., Hoover, R.L., Albertini, D.F., Wright, T.C., Caleb, B.L., and Karnovsky, M.J. Binding and internalization of heparin by vascular smoothmuscle cells. J Cell Physiol 124, 13, 1985.
52. Quarto, N., and Amalric, F. Heparan sulfate proteoglycans as transducers of FGF-2 signalling. J Cell Sci 107 (Pt 11), 3201, 1994.
53. Fasciano, S., Patel, R.C., Handy, I., and Patel, C.V. Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27(kip1). J Biol Chem 280, 15682, 2005.
54. Wright, T.C., Castellot, J.J., Petitou, M., Lormeau, J.C., Choay, J., and Karnovsky, M.J. Structural determinants of heparins growth inhibitory activity-interdependence of oligosaccharide size and charge. J Biol Chem 264, 1534, 1989.
55. Guyton, J.R., Rosenberg, R.D., Clowes, A.W., and Karnovsky, M.J. Inhibition of rat arterial smooth-muscle cell-proliferation by heparin-in vivo studies with anticoagulant and non-anticoagulant heparin. Circ Res 46, 625, 1980.
56. Castellot, J.J., Choay, J., Lormeau, J.C., Petitou, M., Sache, E., and Karnovsky, M.J. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth-muscle cells .2. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group. J Cell Biol 102, 1979, 1986.
57. Garg, H.G., Yu, L., Hales, C.A., Toida, T., Islam, T., and Linhardt, R.J. Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells. Biochim Biophys Acta 1639, 225, 2003.
58. Garg, H.G., Mrabat, H., Yu, L., Freeman, C., Li, B., Zhang, F., Linhardt, R.J., and Hales, C.A. Significance of the 2-Osulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells. Carbohydr Res 343, 2406, 2008.
59. Garg, H.G., Joseph, P.A.M., Thompson, B.T., Hales, C.A., Toida, T., Imanari, T., Capila, I., and Linhardt, R.J. Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation. Arch Biochem Biophys 371, 228, 1999.
60. Hashimoto, T., Kihara, M., Sato, K., Imai, N., Tanaka, Y., Sakai, M., Tamura, K., Hirawa, N., Toya, Y., Kitamura, H., and Umemura, S. Heparin recovers AT1 receptor and its intracellular signal transduction in cultured vascular smooth muscle cells. FEBS Lett 579, 281, 2005.
61. Orlandi, A., Ropraz, P., and Gabbiani, G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth-muscle cells are differently modulated by transforming growth-factor-beta-1 and heparin. Exp Cell Res 214, 528, 1994.
62. Stegemann, J.P., and Nerem, R.M. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two-and three-dimensional culture. Exp Cell Res 283, 146, 2003.
63. Beamish, J.A., Geyer, L.C., Haq-Siddiqi, N.A., Kottke-Marchant, K., and Marchant, R.E. The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype. Biomaterials 30, 6286, 2009.
64. Christen, T., Bochaton-Piallat, M.L., Neuville, P., Rensen, S., Redard, M., van Eys, G., and Gabbiani, G. Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation. Circ Res 85, 99, 1999.
65. Hinck, A.P., Archer, S.J., Qian, S.W., Roberts, A.B., Sporn, M.B., Weatherbee, J.A., Tsang, M.L., Lucas, R., Zhang, B.L., Wenker, J., and Torchia D.A. Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. Biochemistry 35, 8517, 1996.
66. Bjorkerud, S. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 11, 892, 1991.
67. Owens, G.K., Geisterfer, A.A., Yang, Y.W., and Komoriya, A. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107, 771, 1988.
68. Deaton, R.A., Su, C., Valencia, T.G., and Grant, S.R. Transforming growth factor-beta 1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem 280, 31172, 2005.
69. Topouzis, S., and Majesky, M.W. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev Biol 178, 430, 1996.
70. Hautmann, M.B., Madsen, C.S., and Owens, G.K. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272, 10948, 1997.
71. Kawai-Kowase, K., Sato, H., Oyama, Y., Kanai, H., Sato, M., Doi, H., and Kurabayashi, M. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 24, 1384, 2004.
72. Papetti, M., Shujath, J., Riley, K.N., and Herman, I.M. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Invest Ophthalmol Vis Sci 44, 4994, 2003.
73. Grainger, D.J., Metcalfe, J.C., Grace, A.A., and Mosedale, D.E. Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci 111 (Pt 19), 2977, 1998.
74. Alberts, B. Molecular Biology of the Cell, 4th edition. New York: Garland Science, 2002.
75. Nishimura, G., Manabe, I., Tsushima, K., Fujiu, K., Oishi, Y., Imai, Y., Maemura, K., Miyagishi, M., Higashi, Y., Kondoh, H., and Nagai, R. DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation. Dev Cell 11, 93, 2006.
76. Hughes, A.D. Molecular and cellular mechanisms of action of angiotensin II (AT1) receptors in vascular smooth muscle. J Hum Hypertens 12, 275, 1998.
77. 2+ concentration and measurement of cytosolic Na? concentration changes evoked by angiotensin II and vasopressin in individual rat aortic smooth muscle cells. Use of microfluorometry and digital imaging. J Biol Chem 266, 12618, 1991.
78. 2+]i responses to ANG II. Am J Physiol 273, F84, 1997.
79. Geisterfer, A.A., Peach, M.J., and Owens, G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62, 749, 1988.
80. Touyz, R.M., Deng, L.Y., He, G., Wu, X.H., and Schiffrin, E.L. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 17, 907, 1999.
81. deBlois, D., Viswanathan, M., Su, J.E., Clowes, A.W., Saavedra, J.M., and Schwartz, S.M. Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery. Role of AT1 receptor expression. Arterioscler Thromb Vasc Biol 16, 1130, 1996.
82. Ardaillou, R. Angiotensin II receptors. J Am Soc Nephrol 10 Suppl 11, S30, 1999.
83. Zhang, F., Sun, A.S., Yu, L.M., Wu, Q., and Gong, Q.H. Effects of isorhynchophylline on angiotensin II-induced proliferation in rat vascular smooth muscle cells. J Pharm Pharmacol 60, 1673, 2008.
84. Watanabe, T., Pakala, R., Katagiri, T., and Benedict, C.R. Serotonin potentiates angiotensin II-induced vascular smooth muscle cell proliferation. Atherosclerosis 159, 269, 2001.
85. Geisterfer, A.A.T., Peach, M.J., and Owens, G.K. Angiotensin-Ii induces hypertrophy, not hyperplasia, of cultured rat aortic smooth-muscle cells. Circ Res 62, 749, 1988.
86. Bascands, J.L., Girolami, J.P., Troly, M., Escargueil-Blanc, I., Nazzal, D., Salvayre, R., and Blaes, N. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 38, 1294, 2001.
87. Yoshida, T., Hoofnagle, M.H., and Owens, G.K. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res 94, 1075, 2004.
88. Turla, M.B., Thompson, M.M., Corjay, M.H., and Owens, G.K. Mechanisms of angiotensin II-and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression. Circ Res 68, 288, 1991.
89. Chassagne, C., Adamy, C., Ratajczak, P., Gingras, B., Teiger, E., Planus, E., Oliviero, P., Rappaport, L., Samuel, J.L., and Meloche, S. Angiotensin II AT(2) receptor inhibits smooth muscle cell migration via fibronectin cell production and binding. Am J Physiol Cell Physiol 282, C654, 2002.
90. Banskota, N.K., Taub, R., Zellner, K., and King, G.L. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 3, 1183, 1989.
91. Arnqvist, H.J., Bornfeldt, K.E., Chen, Y., and Lindstrom, T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 44, 58, 1995.
92. Hayashi, K., Takahashi, M., Kimura, K., Nishida, W., Saga, H., and Sobue, K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogenactivated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145, 727, 1999.
93. Zhu, B., Zhao, G., Witte, D.P., Hui, D.Y., and Fagin, J.A. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142, 3598, 2001.
94. Moiseeva, E.P. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52, 372, 2001.
95. Hedin, U., Bottger, B.A., Forsberg, E., Johansson, S., and Thyberg, J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 107, 307, 1988.
96. Hayward, I.P., Bridle, K.R., Campbell, G.R., Underwood, P.A., and Campbell, J.H. Effect of extracellular matrix proteins on vascular smooth muscle cell phenotype. Cell Biol Int 19, 839, 1995.
97. Thyberg, J., and Hultgardh-Nilsson, A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res 276, 263, 1994.
98. Yamamoto, M., Yamamoto, K., and Noumura, T. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp Cell Res 204, 121, 1993.
99. Hedin, U.L., Daum, G., and Clowes, A.W. Disruption of integrin alpha 5 beta 1 signaling does not impair PDGF-BBmediated stimulation of the extracellular signal-regulated kinase pathway in smooth muscle cells. J Cell Physiol 172, 109, 1997.
100. Hedin, U., Bottger, B.A., Luthman, J., Johansson, S., and Thyberg, J. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev Biol 133, 489, 1989.
101. Qin, H., Ishiwata, T., Wang, R., Kudo, M., Yokoyama, M., Naito, Z., and Asano, G. Effects of extracellular matrix on phenotype modulation and MAPK transduction of rat aortic smooth muscle cells in vitro. Exp Mol Pathol 69, 79, 2000.
102. Zheng, B., Duan, C., and Clemmons, D.R. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem 273, 8994, 1998.
103. Beamish, J.A., Fu, A.Y., Choi, A.-J., Haq, N.A., Kottke-Marchant, K., and Marchant, R.E. The influence of RGDbearing hydrogels on the re-expression of contractile vascular smooth muscle cell phenotype. Biomaterials 30, 4127, 2009.
104. Hirst, S.J., Twort, C.H., and Lee, T.H. Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol 23, 335, 2000.
105. Tran, T., McNeill, K.D., Gerthoffer, W.T., Unruh, H., and Halayko, A.J. Endogenous laminin is required for human airway smooth muscle cell maturation. Respir Res 7, 117, 2006.
106. Karnik, S.K., Brooke, B.S., Bayes-Genis, A., Sorensen, L., Wythe, J.D., Schwartz, R.S., Keating, M.T., and Li, D.Y. A critical role for elastin signaling in vascular morphogenesis and disease. Development 130, 411, 2003.
107. Hedin, U., Thyberg, J., Roy, J., Dumitrescu, A., and Tran, P.K. Role of tyrosine kinases in extracellular matrixmediated modulation of arterial smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 17, 1977, 1997.
108. Welser, J.V., Lange, N., Singer, C.A., Elorza, M., Scowen, P., Keef, K.D., Gerthoffer, W.T., and Burkin, D.J. Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling. Circ Res 101, 672, 2007.
109. Wilson, E. Alpha 7 beta 1 integrin: putting the brakes on smooth muscle cell proliferation. Circ Res 101, 651, 2007.
110. Lijnen, H.R. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb 33, 275, 2003.
111. Filippov, S., Koenig, G.C., Chun, T.H., Hotary, K.B., Ota, I., Bugge, T.H., Roberts, J.D., Fay, W.P., Birkedal-Hansen, H., Holmbeck, K., Sabeh, F., Allen, E.D., and Weiss, S.J. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J Exp Med 202, 663, 2005.
112. Dollery, C.M., and Libby, P. Atherosclerosis and proteinase activation. Cardiovasc Res 69, 625, 2006.
113. Galis, Z.S., and Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251, 2002.
114. Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S.T., and Clowes, A.W. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 79, 812, 1996.
115. Southgate, K.M., Mehta, D., Izzat, M.B., Newby, A.C., and Angelini, G.D. Increased secretion of basement membranedegrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler Thromb Vasc Biol 19, 1640, 1999.
116. Shofuda, K.I., Hasenstab, D., Kenagy, R.D., Shofuda, T., Li, Z.Y., Lieber, A., and Clowes, A.W. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells. FASEB J 15, 2010, 2001.
117. Mason, D.P., Kenagy, R.D., Hasenstab, D., Bowen-Pope, D.F., Seifert, R.A., Coats, S., Hawkins, S.M., and Clowes, A.W. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85, 1179, 1999.
118. Ailawadi, G., Moehle, C.W., Pei, H., Walton, S.P., Yang, Z., Kron, I.L., Lau, C.L., and Owens, G.K. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg 138, 1392, 2009.
119. Johnson, J.L., van Eys, G.J., Angelini, G.D., and George, S.J. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 21, 1146, 2001.
120. Bendeck, M.P., Zempo, N., Clowes, A.W., Galardy, R.E., and Reidy, M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75, 539, 1994.
121. Zempo, N., Kenagy, R.D., Au, Y.P., Bendeck, M., Clowes, M.M., Reidy, M.A., and Clowes, A.W. Matrix metalloproteinases of vascular wall cells are increased in ballooninjured rat carotid artery. J Vasc Surg 20, 209, 1994.
122. Bendeck, M.P., Irvin, C., and Reidy, M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78, 38, 1996.
123. Lehti, K., Rose, N.F., Valavaara, S., Weiss, S.J., and Keski-Oja, J. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J Cell Sci 122, 126, 2009.
124. Williams, B. Mechanical influences on vascular smooth muscle cell function. J Hypertens 16, 1921, 1998.
125. Wilson, E., Mai, Q., Sudhir, K., Weiss, R.H., and Ives, H.E. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 123, 741, 1993.
126. Wilson, E., Sudhir, K., and Ives, H.E. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest 96, 2364, 1995.
127. Hipper, A., and Isenberg, G. Cyclic mechanical strain decreases the DNA synthesis of vascular smooth muscle cells. Pflugers Arch 440, 19, 2000.
128. Tock, J., Van Putten, V., Stenmark, K.R., and Nemenoff, R.A. Induction of SM-alpha-actin expression by mechanical strain in adult vascular smooth muscle cells is mediated through activation of JNK and p38 MAP kinase. Biochem Biophys Res Commun 301, 1116, 2003.
129. Standley, P.R., Obards, T.J., and Martina, C.L. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia. Am J Physiol 276, E697, 1999.
130. Chapman, G.B., Durante, W., Hellums, J.D., and Schafer, A.I. Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 278, H748, 2000.
131. Qu, M.J., Liu, B., Wang, H.Q., Yan, Z.Q., Shen, B.R., and Jiang, Z.L. Frequency-dependent phenotype modulation of vascular smooth muscle cells under cyclic mechanical strain. J Vasc Res 44, 345, 2007.
132. Birukov, K.G., Shirinsky, V.P., Stepanova, O.V., Tkachuk, V.A., Hahn, A.W., Resink, T.J., and Smirnov, V.N. Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem 144, 131, 1995.
133. Li, W., Chen, Q., Mills, I., and Sumpio, B.E. Involvement of S6 kinase and p38 mitogen activated protein kinase pathways in strain-induced alignment and proliferation of bovine aortic smooth muscle cells. J Cell Physiol 195, 202, 2003.
134. OCallaghan, C.J., and Williams, B. Mechanical straininduced extracellular matrix production by human vascular smooth muscle cells: role of TGF-beta(1). Hypertension 36, 319, 2000.
135. Spofford, C.M., and Chilian, W.M. The elastin-laminin receptor functions as a mechanotransducer in vascular smooth muscle. Am J Physiol Heart Circ Physiol 280, H1354, 2001.
136. Stegemann, J.P., and Nerem, R.M. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng 31, 391, 2003.
137. Jeong, S.I., Kwon, J.H., Lim, J.I., Cho, S.W., Jung, Y., Sung, W.J., Kim, S.H., Kim, Y.H., Lee, Y.M., Kim, B.S., Choi, C.Y., and Kim, S.J. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 26, 1405, 2005.
138. Kim, B.S., Nikolovski, J., Bonadio, J., and Mooney, D.J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 17, 979, 1999.
139. Joki, N., Kaname, S., Hirakata, M., Hori, Y., Yamaguchi, T., Fujita, T., Katoh, T., and Kurokawa, K. Tyrosine-kinase dependent TGF-beta and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells. Hypertens Res 23, 91, 2000.
140. Mann, B.K., Schmedlen, R.H., and West, J.L. Tethered-TGFbeta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22, 439, 2001.
141. Hahn, M.S., McHale, M.K., Wang, E., Schmedlen, R.H., and West, J.L. Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts. Ann Biomed Eng 35, 190, 2007.
142. Bulick, A.S., Munoz-Pinto, D.J., Qu, X., Mani, M., Cristancho, D., Urban, M., and Hahn, M.S. Impact of endothelial cells and mechanical conditioning on smooth muscle cell extracellular matrix production and differentiation. Tissue Eng Part A 15, 815, 2009.
143. Reusch, P., Wagdy, H., Reusch, R., Wilson, E., and Ives, H.E. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 79, 1046, 1996.
144. Reusch, H.P., Chan, G., Ives, H.E., and Nemenoff, R.A. Activation of JNK/SAPK and ERK by mechanical strain in vascular smooth muscle cells depends on extracellular matrix composition. Biochem Biophys Res Commun 237, 239, 1997.
145. Chen, Q., Li, W., Quan, Z., and Sumpio, B.E. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogenactivated protein kinase. J Vasc Surg 37, 660, 2003.
146. Standley, P.R., Cammarata, A., Nolan, B.P., Purgason, C.T., and Stanley, M.A. Cyclic stretch induces vascular smooth muscle cell alignment via NO signaling. Am J Physiol Heart Circ Physiol 283, H1907, 2002.
147. Li, Q., Muragaki, Y., Hatamura, I., Ueno, H., and Ooshima, A. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factorbeta. J Vasc Res 35, 93, 1998.
148. Cappadona, C., Redmond, E.M., Theodorakis, N.G., McKillop, I.H., Hendrickson, R., Chhabra, A., Sitzmann, J.V., and Cahill, P.A. Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro. Exp Cell Res 250, 174, 1999.
149. Jackson, Z.S., Gotlieb, A.I., and Langille, B.L. Wall tissue remodeling regulates longitudinal tension in arteries. Circ Res 90, 918, 2002.
150. Nichol, J.W., Petko, M., Myung, R.J., Gaynor, J.W., and Gooch, K.J. Hemodynamic conditions alter axial and circumferential remodeling of arteries engineered ex vivo. Ann Biomed Eng 33, 721, 2005.
151. Davies, P.F., Olesen, S.P., Clapham, D.E., Morrel, E.M., and Schoen, F.J. Endothelial communication-state of the art lecture. Hypertension 11, 563, 1988.
152. Thomae, K.R., Nakayama, D.K., Billiar, T.R., Simmons, R.L., Pitt, B.R., and Davies, P. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 59, 337, 1995.
153. Janakidevi, K., Fisher, M.A., Del Vecchio, P.J., Tiruppathi, C., Figge, J., and Malik, A.B. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 263, C1295, 1992.
154. Fillinger, M.F., Sampson, L.N., Cronenwett, J.L., Powell, R.J., and Wagner, R.J. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res 67, 169, 1997.
155. Heydarkhan-Hagvall, S., Helenius, G., Johansson, B.R., Li, J.Y., Mattsson, E., and Risberg, B. Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J Cell Biochem 89, 1250, 2003.
156. Rose, S.L., and Babensee, J.E. Complimentary endothelial cell/smooth muscle cell co-culture systems with alternate smooth muscle cell phenotypes. Ann Biomed Eng 35, 1382, 2007.
157. Rose, S.L., and Babensee, J.E. Smooth muscle cell phenotype alters cocultured endothelial cell response to biomaterial-pretreated leukocytes. J Biomed Mater Res A 84, 661, 2008.
158. Yoshida, H., Nakamura, M., Makita, S., and Hiramori, K. Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: transmembrane co-culture method. Heart Vessels 11, 229, 1996.
159. Williams, C., and Wick, T.M. Endothelial cell-smooth muscle cell co-culture in a perfusion bioreactor system. Ann Biomed Eng 33, 920, 2005.
160. Haruguchi, H., and Teraoka, S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs 6, 227, 2003.
161. Motwani, J.G., and Topol, E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97, 916, 1998.
162. Hancock, W.W., Adams, D.H., Wyner, L.R., Sayegh, M.H., and Karnovsky, M.J. CD4? mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol 145, 1008, 1994.
163. Tanaka, H., Sukhova, G.K., Swanson, S.J., Clinton, S.K., Ganz, P., Cybulsky, M.I., and Libby, P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 88, 1788, 1993.
164. Okamoto, E., Couse, T., De Leon, H., Vinten-Johansen, J., Goodman, R.B., Scott, N.A., and Wilcox, J.N. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 104, 2228, 2001.
165. Schultz, K., Murthy, V., Tatro, J.B., and Beasley, D. Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 292, H2927, 2007.
166. Yue, T.L., Wang, X., Sung, C.P., Olson, B., McKenna, P.J., Gu, J.L., and Feuerstein, G.Z. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 75, 1, 1994.
167. Cirillo, P., Golino, P., Calabro, P., Cali, G., Ragni, M., De Rosa, S., Cimmino, G., Pacileo, M., De Palma, R., Forte, L., Gargiulo, A., Corigliano, F.G., Angri, V., Spagnuolo, R., Nitsch, L., and Chiariello, M. C-Reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68, 47, 2005.
168. Heo, S.K., Yun, H.J., Park, W.H., and Park, S.D. Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell proliferation via caspase-and mitochondrial-dependent apoptosis. J Cell Biochem 105, 70, 2008.
169. Miano, J.M., Long, X., and Fujiwara, K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292, C70, 2007.
170. Miano, J.M. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35, 577, 2003.
171. Prywes, R., and Roeder, R.G. Purification of the c-fos enhancer-binding protein. Mol Cell Biol 7, 3482, 1987.
172. Treisman, R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46, 567, 1986.
173. Norman, C., Runswick, M., Pollock, R., and Treisman, R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55, 989, 1988.
174. Boxer, L.M., Prywes, R., Roeder, R.G., and Kedes, L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol Cell Biol 9, 515, 1989.
175. Sun, Q., Chen, G., Streb, J.W., Long, X., Yang, Y., Stoeckert, C.J., Jr., and Miano, J.M. Defining the mammalian CAr-Gome. Genome Res 16, 197, 2006.
176. Yoshida, T., Kawai-Kowase, K., and Owens, G.K. Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler Thromb Vasc Biol 24, 1596, 2004.
177. Wang, D., Chang, P.S., Wang, Z., Sutherland, L., Richardson, J.A., Small, E., Krieg, P.A., and Olson, E.N. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851, 2001.
178. Mack, C.P., and Hinson, J.S. Regulation of smooth muscle differentiation by the myocardin family of serum response factor co-factors. J Thromb Haemost 3, 1976, 2005.
179. Wang, Z., Wang, D.Z., Pipes, G.C., and Olson, E.N. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A 100, 7129, 2003.
180. Hendrix, J.A., Wamhoff, B.R., McDonald, O.G., Sinha, S., Yoshida, T., and Owens, G.K. 5? CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest 115, 418, 2005.
181. van Tuyn, J., Knaan-Shanzer, S., van de Watering, M.J., de Graaf, M., van der Laarse, A., Schalij, M.J., van der Wall, E.E., de Vries, A.A., and Atsma, D.E. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc Res 67, 245, 2005.
182. Manabe, I., and Owens, G.K. Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ Res 88, 1127, 2001.
183. Li, S., Wang, D.Z., Wang, Z., Richardson, J.A., and Olson, E.N. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A 100, 9366, 2003.
184. Pipes, G.C., Sinha, S., Qi, X., Zhu, C.H., Gallardo, T.D., Shelton, J., Creemers, E.E., Sutherland, L., Richardson, J.A., Garry, D.J., Wright, W.E., Owens, G.K., and Olson, E.N. Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression. Dev Biol 288, 502, 2005.
185. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767, 2004.
186. Kawai-Kowase, K., Kumar, M.S., Hoofnagle, M.H., Yoshida, T., and Owens, G.K. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helixloop-helix proteins. Mol Cell Biol 25, 8009, 2005.
187. Gan, Q., Yoshida, T., Li, J., and Owens, G.K. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res 101, 883, 2007.
188. Miralles, F., Posern, G., Zaromytidou, A.I., and Treisman, R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329, 2003.
189. Cavigelli, M., Dolfi, F., Claret, F.X., and Karin, M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J 14, 5957, 1995.
190. Zhou, J., Hu, G., and Herring, B.P. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol 25, 9874, 2005.
191. Yoshida, T., Gan, Q., and Owens, G.K. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol 295, C1175, 2008.
192. Wang, Z., Wang, D.Z., Hockemeyer, D., McAnally, J., Nordheim, A., and Olson, E.N. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428, 185, 2004.
193. Liu, Y., Sinha, S., and Owens, G. A transforming growth factor-beta control element required for SM alphaactin expression in vivo also partially mediates GKLFdependent transcriptional repression. J Biol Chem 278, 48004, 2003.
194. Adam, P.J., Regan, C.P., Hautmann, M.B., and Owens, G.K. Positive-and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275, 37798, 2000.
195. Liu, Y., Sinha, S., McDonald, O.G., Shang, Y., Hoofnagle, M.H., and Owens, G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280, 9719, 2005.
196. Kawai-Kowase, K., Ohshima, T., Matsui, H., Tanaka, T., Shimizu, T., Iso, T., Arai, M., Owens, G.K., and Kurabayashi, M. PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler Thromb Vasc Biol 29, 99, 2009.
197. Doi, H., Iso, T., Yamazaki, M., Akiyama, H., Kanai, H., Sato, H., Kawai-Kowase, K., Tanaka, T., Maeno, T., Okamoto, E., Arai, M., Kedes, L., and Kurabayashi, M. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler Thromb Vasc Biol 25, 2328, 2005.
198. Dandre, F., and Owens, G.K. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol 286, H2042, 2004.
199. Shen, J.Y., Chan-Park, M.B., He, B., Zhu, A.P., Zhu, X., Beuerman, R.W., Yang, E.B., Chen, W., and Chan, V. Threedimensional microchannels in biodegradable polymeric films for control orientation and phenotype of vascular smooth muscle cells. Tissue Eng 12, 2229, 2006.
200. Rowlands, A.S., and Cooper-White, J.J. Directing phenotype of vascular smooth muscle cells using electrically stimulated conducting polymer. Biomaterials 29, 4510, 2008.
201. Higgins, S.P., Solan, A.K., and Niklason, L.E. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A 67, 295, 2003.
202. Mann, B.K., Tsai, A.T., Scott-Burden, T., and West, J.L. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials 20, 2281, 1999.
203. Mann, B.K., and West, J.L. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 60, 86, 2002.
204. Joddar, B., Ibrahim, S., and Ramamurthi, A. Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials 28, 3918, 2007.
205. Peyton, S.R., Raub, C.B., Keschrumrus, V.P., and Putnam, A.J. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 27, 4881, 2006.
206. Li, S., Lao, J., Chen, B.P., Li, Y.S., Zhao, Y., Chu, J., Chen, K.D., Tsou, T.C., Peck, K., and Chien, S. Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J 17, 97, 2003.
207. Hong, H., McCullough, C.M., and Stegemann, J.P. The role of ERK signaling in protein hydrogel remodeling by vascular smooth muscle cells. Biomaterials 28, 3824, 2007.
208. Mann, B.K., Gobin, A.S., Tsai, A.T., Schmedlen, R.H., and West, J.L. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 22, 3045, 2001.
209. Adelow, C., Segura, T., Hubbell, J.A., and Frey, P. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials 29, 314, 2008.
210. Peyton, S.R., Kim, P.D., Ghajar, C.M., Seliktar, D., and Putnam, A.J. The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 29, 2597, 2008.
211. Brophy, C.M., Woodrum, D.A., Pollock, J., Dickinson, M., Komalavilas, P., Cornwell, T.L., and Lincoln, T.M. cGMPdependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J Vasc Res 39, 95, 2002.
212. Stegemann, J.P., Dey, N.B., Lincoln, T.M., and Nerem, R.M. Genetic modification of smooth muscle cells to control phenotype and function in vascular tissue engineering. Tissue Eng 10, 189, 2004.
213. 2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res 95, 406, 2004.
214. L?Heureux, N., Stoclet, J.-C., Auger, F.A., Lagaud, G.J.-L., Germain, L., and Andriantsitohaina, R. A human tissueengineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J 15, 515, 2001.
215. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., and Langer, R. Functional arteries grown in vitro. Science 284, 489, 1999.
216. Weinberg, C.B., and Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397, 1986.
217. Chan-Park, M.B., Shen, J.Y., Cao, Y., Xiong, Y., Liu, Y., Rayatpisheh, S., Kang, G.C., and Greisler, H.P. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. J Biomed Mater Res A 88, 1104, 2009.
218. Kakisis, J.D., Liapis, C.D., Breuer, C., and Sumpio, B.E. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg 41, 349, 2005.
219. Borschel, G.H., Huang, Y.C., Calve, S., Arruda, E.M., Lynch, J.B., Dow, D.E., Kuzon, W.M., Dennis, R.G., and Brown, D.L. Tissue engineering of recellularized smalldiameter vascular grafts. Tissue Eng 11, 778, 2005.
220. Kaushal, S., Amiel, G.E., Guleserian, K.J., Shapira, O.M., Perry, T., Sutherland, F.W., Rabkin, E., Moran, A.M., Schoen, F.J., Atala, A., Soker, S., Bischoff, J., and Mayer, J.E. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7, 1035, 2001.
221. Huynh, T., Abraham, G., Murray, J., Brockbank, K., Hagen, P.O., and Sullivan, S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17, 1083, 1999.
222. Tranquillo, R.T., Girton, T.S., Bromberek, B.A., Triebes, T.G., and Mooradian, D.L. Magnetically orientated tissueequivalent tubes: application to a circumferentially orientated media-equivalent. Biomaterials 17, 349, 1996.
223. Seliktar, D., Black, R.A., Vito, R.P., and Nerem, R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 28, 351, 2000.
224. Seliktar, D., Nerem, R.M., and Galis, Z.S. Mechanical strainstimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng 9, 657, 2003.
225. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. A fibrinbased arterial media equivalent. J Biomed Mater Res Part A 66A, 550, 2003.
226. Swartz, D.D., Russell, J.A., and Andreadis, S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 288, H1451, 2005.
227. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin?oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
228. Shin?oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., Sakamoto, T., Nagatsu, M., and Kurosawa, H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129, 1330, 2005.
229. Shum-Tim, D., Stock, U., Hrkach, J., Shinoka, T., Lien, J., Moses, M.A., Stamp, A., Taylor, G., Moran, A.M., Landis, W., Langer, R., Vacanti, J.P., and Mayer, J.E. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68, 2298, 1999.
230. Tillman, B.W., Yazdani, S.K., Lee, S.J., Geary, R.L., Atala, A., and Yoo, J.J. The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 30, 583, 2009.
231. Hashi, C.K., Zhu, Y.Q., Yang, G.Y., Young, W.L., Hsiao, B.S., Wang, K., Chu, B., and Li, S. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A 104, 11915, 2007.
232. Stitzel, J., Liu, L., Lee, S.J., Komura, M., Berry, J., Soker, S., Lim, G., Van Dyke, M., Czerw, R., Yoo, J.J., and Atala, A. Controlled fabrication of a biological vascular substitute. Biomaterials 27, 1088, 2006.
233. L?Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12, 47, 1998.
234. L?Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., Chronos, N.A., Kyles, A.E., Gregory, C.R., Hoyt, G., Robbins, R.C., and McAllister, T.N. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12, 361, 2006.
235. McAllister, T.N., Maruszewski, M., Garrido, S.A., Wystrychowski, W., Dusserre, N., Marini, A., Zagalski, K., Fiorillo, A., Avila, H., Manglano, X., Antonelli, J., Kocher, A., Zembala, M., Cierpka, L., de la Fuente, L.M., and L?Heureux, N. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373, 1440, 2009.
236. Xie, C.Q., Huang, H., Wei, S., Song, L.S., Zhang, J., Ritchie, R.P., Chen, L., Zhang, M., and Chen, Y.E. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 18, 741, 2009.
237. Liu, J.Y., Swartz, D.D., Peng, H.F., Gugino, S.F., Russell, J.A., and Andreadis, S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res 75, 618, 2007.
238. Liu, J.Y., Peng, H.F., and Andreadis, S.T. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res 79, 24, 2008.
239. Huang, H., Zhao, X., Chen, L., Xu, C., Yao, X., Lu, Y., Dai, L., and Zhang, M. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 351, 321, 2006.
240. Drab, M., Haller, H., Bychkov, R., Erdmann, B., Lindschau, C., Haase, H., Morano, I., Luft, F.C., and Wobus, A.M. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J 11, 905, 1997.
241. Lee, T.H., Song, S.H., Kim, K.L., Yi, J.Y., Shin, G.H., Kim, J.Y., Kim, J., Han, Y.M., Lee, S.H., Lee, S.H., Shim, S.H., and Suh W. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ Res 106, 120, 2010.
242. Liao, S.W., Hida, K., Park, J.S., and Li, S. Mechanical regulation of matrix reorganization and phenotype of smooth muscle cells and mesenchymal stem cells in 3D matrix. Conf Proc IEEE Eng Med Biol Soc 7, 5024, 2004.
243. Wang, C., Yin, S., Cen, L., Liu, Q., Liu, W., Cao, Y., and Cui, L. Differentiation of adipose derived stem cells into contractile smooth muscle cells induced by TGF-beta1 and BMP4. Tissue Eng Part A 16, 1201, 2010.
244. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
245. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007.
246. Suzuki, S., Narita, Y., Yamawaki, A., Murase, Y., Satake, M., Mutsuga, M., Okamoto, H., Kagami, H., Ueda, M., and Ueda, Y. Effects of extracellular matrix on differentiation of human bone marrow-derived mesenchymal stem cells into smooth muscle cell lineage: utility for cardiovascular tissue engineering. Cells Tissues Organs 191, 269, 2009.
247. Owens, G.K., Loeb, A., Gordon, D., and Thompson, M.M. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol 102, 343, 1986.
248. Kim, H.R., Gallant, C., Leavis, P.C., Gunst, S.J., and Morgan, K.G. Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. Am J Physiol Cell Physiol 295, C768, 2008.
249. Duband, J.L., Gimona, M., Scatena, M., Sartore, S., and Small, J.V. Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation 55, 1, 1993.
250. Deissler, H., Deissler, H., Lang, G.K., and Lang, G.E. TGFbeta induces transdifferentiation of iBREC to alphaSMA-expressing cells. Int J Mol Med 18, 577, 2006.
251. Arciniegas, E., Sutton, A.B., Allen, T.D., and Schor, A.M. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 103 (Pt 2), 521, 1992.
252. Winder, S.J., and Walsh, M.P. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 265, 10148, 1990.
253. Leinweber, B., Parissenti, A.M., Gallant, C., Gangopadhyay, S.S., Kirwan-Rhude, A., Leavis, P.C., and Morgan, K.G. Regulation of protein kinase C by the cytoskeletal protein calponin. J Biol Chem 275, 40329, 2000.
254. Leinweber, B.D., Leavis, P.C., Grabarek, Z., Wang, C.L., and Morgan, K.G. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J 344 Pt 1, 117, 1999.
255. Morgan, K.G., and Gangopadhyay, S.S. Invited review: cross-bridge regulation by thin filament-associated proteins. J Appl Physiol 91, 953, 2001.
256. Miano, J.M., and Olson, E.N. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem 271, 7095, 1996.
257. Burgstaller, G., Kranewitter, W.J., and Gimona, M. The molecular basis for the autoregulation of calponin by isoform-specific C-terminal tail sequences. J Cell Sci 115, 2021, 2002.
258. Yoshikawa, H., Taniguchi, S.I., Yamamura, H., Mori, S., Sugimoto, M., Miyado, K., Nakamura, K., Nakao, K., Katsuki, M., Shibata, N., and Takahashi, K. Mice lacking smooth muscle calponin display increased bone formation that is associated with enhancement of bone morphogenetic protein responses. Genes Cells 3, 685, 1998.
259. Masuki, S., Takeoka, M., Taniguchi, S., and Nose, H. Enhanced baroreflex sensitivity in free-moving calponin knockout mice. Am J Physiol Heart Circ Physiol 284, H939, 2003.
260. Masuki, S., Takeoka, M., Taniguchi, S., Yokoyama, M., and Nose, H. Impaired arterial pressure regulation during exercise due to enhanced muscular vasodilatation in calponin knockout mice. J Physiol 553, 203, 2003.
261. Matthew, J.D., Khromov, A.S., McDuffie, M.J., Somlyo, A.V., Somlyo, A.P., Taniguchi, S., and Takahashi, K. Contractile properties and proteins of smooth muscles of a calponin knockout mouse. J Physiol 529 Pt 3, 811, 2000.
262. Je, H.D., and Sohn, U.D. SM22alpha is required for agonistinduced regulation of contractility: evidence from SM22-alpha knockout mice. Mol Cells 23, 175, 2007.
263. Lepore, J.J., Cheng, L., Min Lu, M., Mericko, P.A., Morrisey, E.E., and Parmacek, M.S. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis 41, 179, 2005.
264. Zhang, J.C., Kim, S., Helmke, B.P., Yu, W.W., Du, K.L., Lu, M.M., Strobeck, M., Yu, Q., and Parmacek, M.S. Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol 21, 1336, 2001.
265. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 78, 188, 1996.
266. Faggin, E., Puato, M., Zardo, L., Franch, R., Millino, C., Sarinella, F., Pauletto, P., Sartore, S., and Chiavegato, A. Smooth muscle-specific SM22 protein is expressed in the adventitial cells of balloon-injured rabbit carotid artery. Arterioscler Thromb Vasc Biol 19, 1393, 1999.
267. Sobue, K., and Sellers, J.R. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 266, 12115, 1991.
268. Babu, G.J., Warshaw, D.M., and Periasamy, M. Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 50, 532, 2000.
269. Frid, M.G., Printesva, O.Y., Chiavegato, A., Faggin, E., Scatena, M., Koteliansky, V.E., Pauletto, P., Glukhova, M.A., and Sartore, S. Myosin heavy-chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res 30, 279, 1993.
270. Babu, G.J., Pyne, G.J., Zhou, Y., Okwuchukuasanya, C., Brayden, J.E., Osol, G., Paul, R.J., Low, R.B., and Periasamy, M. Isoform switching from SM-B to SM-A myosin results in decreased contractility and altered expression of thin filament regulatory proteins. Am J Physiol Cell Physiol 287, C723, 2004.
271. Lauzon, A.M., Tyska, M.J., Rovner, A.S., Freyzon, Y., Warshaw, D.M., and Trybus, K.M. A 7-amino-acid insert in the heavy chain nucleotide binding loop alters the kinetics of smooth muscle myosin in the laser trap. J Muscle Res Cell Motil 19, 825, 1998.
272. Babij, P., Kawamoto, S., White, S., Adelstein, R.S., and Periasamy, M. Differential expression of SM1 and SM2 myosin isoforms in cultured vascular smooth muscle. Am J Physiol 262, C607, 1992.
273. Kuro-o, M., Nagai, R., Nakahara, K., Katoh, H., Tsai, R.C., Tsuchimochi, H., Yazaki, Y., Ohkubo, A., and Takaku, F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 266, 3768, 1991.
274. Miano, J.M., Cserjesi, P., Ligon, K.L., Periasamy, M., and Olson, E.N. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res 75, 803, 1994.
275. Chi, M., Zhou, Y., Vedamoorthyrao, S., Babu, G.J., and Periasamy, M. Ablation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in mice. Proc Natl Acad Sci U S A 105, 18614, 2008.
276. Rensen, S.S., Thijssen, V.L., De Vries, C.J., Doevendans, P.A., Detera-Wadleigh, S.D., and Van Eys, G.J. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res 55, 850, 2002.
277. van Eys, G.J., Niessen, P.M., and Rensen, S.S. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc Med 17, 26, 2007.
278. Niessen, P., Clement, S., Fontao, L., Chaponnier, C., Teunissen, B., Rensen, S., van Eys, G., and Gabbiani, G. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp Cell Res 292, 170, 2004.
279. Deruiter, M.C., Rensen, S.S., Coolen, G.P., Hierck, B.P., Bergwerff, M., Debie, W.M., Gittenberger-De Groot, A.C., and Van Eys, G.J. Smoothelin expression during chicken embryogenesis: detection of an embryonic isoform. Dev Dyn 221, 460, 2001.
280. Rensen, S.S., Niessen, P.M., van Deursen, J.M., Janssen, B.J., Heijman, E., Hermeling, E., Meens, M., Lie, N., Gijbels, M.J., Strijkers, G.J., Doevendans, P.A., Hofker, M.H., De Mey, J.G., and van Eys, G.J. Smoothelin-B deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice. Circulation 118, 828, 2008.
281. Layne, M.D., Endege, W.O., Jain, M.K., Yet, S.F., Hsieh, C.M., Chin, M.T., Perrella, M.A., Blanar, M.A., Haber, E., and Lee, M.E. Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. J Biol Chem 273, 15654, 1998.
282. Layne, M.D., Yet, S.F., Maemura, K., Hsieh, C.M., Liu, X., Ith, B., Lee, M.E., and Perrella, M.A. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ Res 90, 728, 2002.
283. Yoshida, T., Gan, Q., Shang, Y., and Owens, G.K. Plateletderived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol 292, C886, 2007.
284. Li, S., Sims, S., Jiao, Y., Chow, L.H., and Pickering, J.G. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ Res 85, 338, 1999.
285. Sobue, K., Hayashi, K., and Nishida, W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 190, 105, 1999.
286. Hayashi, K., Kanda, K., Kimizuka, F., Kato, I., and Sobue, K. Primary structure and functional expression of hcaldesmon complementary DNA. Biochem Biophys Res Commun 164, 503, 1989.
287. Hayashi, K., Fujio, Y., Kato, I., and Sobue, K. Structural and functional relationships between h-and l-caldesmons. J Biol Chem 266, 355, 1991.
288. Lane, E.B., Hogan, B.L., Kurkinen, M., and Garrels, J.I. Coexpression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 303, 701, 1983.
289. Kim, S., and Coulombe, P.A. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev 21, 1581, 2007.
290. Tapscott, S.J., Bennett, G.S., Toyama, Y., Kleinbart, F., and Holtzer, H. Intermediate filament proteins in the developing chick spinal cord. Dev Biol 86, 40, 1981.
291. Lazarides, E. Intermediate filaments as mechanical integrators of cellular space. Nature 283, 249, 1980.
292. Osborn, M. Intermediate filaments as histologic markers: an overview. J Invest Dermatol 81, 104s, 1983.
293. Goldman, R.D., Khuon, S., Chou, Y.H., Opal, P., and Steinert, P.M. The function of intermediate filaments in cell shape and cytoskeletal integrity. J Cell Biol 134, 971, 1996.
294. Wang, N., Stamenovic, D. Mechanics of vimentin intermediate filaments. J Muscle Res Cell Motil 23, 535, 2002.
295. Asada, H., Paszkowiak, J., Teso, D., Alvi, K., Thorisson, A., Frattini, J.C., Kudo, F.A., Sumpio, B.E., and Dardik, A. Sustained orbital shear stress stimulates smooth muscle cell proliferation via the extracellular signal-regulated protein kinase 1/2 pathway. J Vasc Surg 42, 772, 2005.
296. Zhou, W., Dasgupta, C., Negash, S., and Raj, J.U. Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase. Am J Physiol Lung Cell Mol Physiol 292, L1459, 2007.
297. Skalli, O., Bloom, W.S., Ropraz, P., Azzarone, B., and Gabbiani, G. Cytoskeletal remodeling of rat aortic smoothmuscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. J Submicrosc Cytol 18, 481, 1986.
298. Gilles, C., Polette, M., Piette, J., Delvigne, A.C., Thompson, E.W., Foidart, J.M., and Birembaut, P. Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol 180, 175, 1996.
299. Singh, S., Sadacharan, S., Su, S., Belldegrun, A., Persad, S., and Singh, G. Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res 63, 2306, 2003.
300. Kuro-o, M., Nagai, R., Tsuchimochi, H., Katoh, H., Yazaki, Y., Ohkubo, A., and Takaku, F. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 264, 18272, 1989.
301. Aikawa, M., Sivam, P.N., Kuro-o, M., Kimura, K., Nakahara, K., Takewaki, S., Ueda, M., Yamaguchi, H., Yazaki, Y., and Periasamy, M., et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 73, 1000, 1993.
302. Itoh, K., and Adelstein, R.S. Neuronal cell expression of inserted isoforms of vertebrate nonmuscle myosin heavy chain II-B. J Biol Chem 270, 14533, 1995.
303. Kawamoto, S. Neuron-specific alternative splicing of nonmuscle myosin II heavy chain-B pre-mRNA requires a cisacting intron sequence. J Biol Chem 271, 17613, 1996.
304. Rochlin, M.W., Itoh, K., Adelstein, R.S., and Bridgman, P.C. Localization of myosin II A and B isoforms in cultured neurons. J Cell Sci 108 (Pt 12), 3661, 1995.
305. Abouhamed, M., Reichenberg, S., Robenek, H., and Plenz, G. Tropomyosin 4 expression is enhanced in dediffer-entiating smooth muscle cells in vitro and during atherogenesis. Eur J Cell Biol 82, 473, 2003.
306. Gunning, P., Gordon, M., Wade, R., Gahlmann, R., Lin, C.S., and Hardeman, E. Differential control of tropomyosin mRNA levels during myogenesis suggests the existence of an isoform competition-autoregulatory compensation control mechanism. Dev Biol 138, 443, 1990.
307. Helfman, D.M., Berthier, C., Grossman, J., Leu, M., Ehler, E., Perriard, E., and Perriard, J.C. Nonmuscle tropomyosin-4 requires coexpression with other low molecular weight isoforms for binding to thin filaments in cardiomyocytes. J Cell Sci 112 (Pt 3), 371, 1999.
308. Vlahovich, N., Schevzov, G., Nair-Shaliker, V., Ilkovski, B., Artap, S.T., Joya, J.E., Kee, A.J., North, K.N., Gunning, P.W., and Hardeman, E.C. Tropomyosin 4 defines novel filaments in skeletal muscle associated with muscle remodelling/regeneration in normal and diseased muscle. Cell Motil Cytoskeleton 65, 73, 2008.
309. Neuville, P., Geinoz, A., Benzonana, G., Redard, M., Gabbiani, F., Ropraz, P., and Gabbiani, G. Cellular retinolbinding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol 150, 509, 1997.
310. Uchio, K., Tuchweber, B., Manabe, N., Gabbiani, G., Rosenbaum, J., and Desmouliere, A. Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 82, 619, 2002.
311. Xu, G., Redard, M., Gabbiani, G., and Neuville, P. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol 151, 1741, 1997.
312. Orlandi, A., Francesconi, A., Clement, S., Ropraz, P., Spagnoli, L.G., and Gabbiani, G. High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation. Virchows Arch 441, 31, 2002.